Table 2.
Antibiotics | Financial year |
|||
---|---|---|---|---|
2014–15 | 2015–16 | 2016–17 | 2017–18 | |
Total, median (IQR) items per 1000 STAR-PU | 1353 (1157–1557) | 1278.6 (1081.6–1453.6) | 1230.4 (1049.3–1392.1) | 1199.8 (1043.7–1363.0) |
Co-amoxiclav, median (IQR) items per 1000 registered patients | 29.22 (19.20–41.26) | 23.81 (15.76–33.97) | 21.59 (14.73–30.14) | 20.65 (14.04–27.95) |
Cephalosporins, median (IQR) items per 1000 registered patients | 27.15 (18.27–40.27) | 23.65 (14.74–34.59) | 20.81 (12.12–29.70) | 18.45 (11.04–27.86) |
Clindamycin, median (IQR) items per 1000 registered patients | 0.75 (0.27–1.81) | 0.88 (0.31–1.84) | 0.97 (0.44–2.08) | 1.04 (0.39–2.02) |
Quinolones, median (IQR) items per 1000 registered patients | 14.49 (10.77–19.12) | 13.13 (9.62–17.33) | 12.97 (9.59–16.73) | 12.39 (8.82–16.77) |